Aspirin-induced inhibition of β-catenin and NFκB have also been associated with the anticancer activity of aspirin [12]–[15], and we have previously identified that p65-NFκB expression was regulated by Sp transcription factors in colon and bladder cancer cells [22], [25]. This evidence concerns the gene TFF2 and urinary bladder cancer.